Kadmon Holdings, Inc. (KDMN) financial statements (2021 and earlier)

Company profile

Business Address 450 EAST 29TH STREET
NEW YORK, NY 10016
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13416018214818212386
Cash and cash equivalents741061701201406686
Short-term investments605412284256 
Receivables1001111
Inventory, net of allowances, customer advances and progress billings0001100
Inventory0001100
Other undisclosed current assets2233111
Total current assets:13716218515318512489
Noncurrent Assets
Operating lease, right-of-use asset1617181920  
Property, plant and equipment1222233
Long-term investments and receivables2   2 95
Long-term investments2   2 95
Intangible assets, net (including goodwill)4444444
Goodwill4444444
Restricted cash and investments2222222
Other noncurrent assets000000 
Other undisclosed noncurrent assets 222 2324
Total noncurrent assets:252728293031127
TOTAL ASSETS:163189213182215156216
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22222318232221
Accounts payable1112127987
Accrued liabilities12101112141414
Debt25544  
Derivative instruments and hedges, liabilities1121110
Other undisclosed current liabilities4    328
Total current liabilities:29283024295430
Noncurrent Liabilities
Long-term debt and lease obligation1719191920 23
Long-term debt, excluding current maturities122   23
Operating lease, liability1617181920  
Liabilities, other than long-term debt0000110
Deferred tax liabilities, net00
Deferred income tax liabilities00000  
Other liabilities    00 
Other undisclosed noncurrent liabilities     2122
Total noncurrent liabilities:17192019202145
Total liabilities:47485043497675
Stockholders' equity
Stockholders' equity attributable to parent11614116313916680141
Preferred stock45444343424241
Common stock0000000
Additional paid in capital515513510459456359357
Accumulated other comprehensive loss(0)(0)     
Accumulated deficit(444)(416)(391)(363)(333)(321)(258)
Total stockholders' equity:11614116313916680141
TOTAL LIABILITIES AND EQUITY:163189213182215156216

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues1007400
Gain on disposition of assets for financial service operations 416    
Cost of revenue
(Cost of Goods and Services Sold)
0(0)(1)(0)0 (1)
Other undisclosed gross profit(0)(0)(0)(0)(0)(0)(0)
Gross profit:00(0)640(1)
Operating expenses(32)(28)(27)(22)(22)(23)(24)
Operating loss:(31)(28)(27)(16)(18)(23)(25)
Nonoperating income (expense)33(0)(13)7(39)34
Investment income, nonoperating 1(0)1(23)(38)35
Gain on contract termination 2     
Other nonoperating income (expense) (0)00(0)0(0)
Interest and debt expense4(0)(0) (1)(1)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(24)(25)(27)(29)(12)(63)8
Other undisclosed income (loss) from continuing operations before income taxes(4)00 111
Income (loss) from continuing operations before income taxes:(28)(25)(27)(29)(12)(62)9
Other undisclosed income (loss) from continuing operations0   (0)  
Net income (loss) attributable to parent:(28)(25)(27)(29)(12)(62)9
Preferred stock dividends and other adjustments(1)(1)(1)(1)(1)(1)(1)
Net income (loss) available to common stockholders, diluted:(28)(25)(28)(30)(12)(63)9

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(28)(25)(27)(29)(12)(62)9
Other undisclosed comprehensive loss(2)      
Comprehensive income (loss):(30)(25)(27)(29)(12)(62)9
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(1)     
Comprehensive income (loss), net of tax, attributable to parent:(28)(25)(27)(29)(12)(62)9

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: